Skip to content

Intraoperative Analysis of the Central Retina in ERF

Intraoperative Analysis of the Central Retina in Epiretinal Fibrosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04802915
Enrollment
60
Registered
2021-03-17
Start date
2019-01-15
Completion date
2022-12-31
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epiretinal Membrane, Macular Pucker

Keywords

epiretinal membrane, internal limiting membrane, epiretinal fibrosis, macular pucker, central retina

Brief summary

Changes in the retinal anatomy that occur in epiretinal fibrosis have not been sufficiently studied. It is possible that epiretinal fibrosis leads not only to traction dislocation of the macula, but also to ILM anatomical disorders.

Detailed description

Purpose: to study anatomical changes in the Central retina in epiretinal fibrosis. Surgical treatment: standard vitrectomy 25-27G; ERM amd ILM stainig by Membrane Blue Dual; epiretinal membrane removal, ILM peeling if the divulsion of ILM was detected. Expected results: improving the quality of epiretinal fibrosis surgery by obtaining a more detailed picture of the pathological process

Interventions

PROCEDUREIntraoperative ERM and ILM staining with their assessment and removal

ERM and ILM staining is performed after vitrectomy. After that we evaluate the condition of macular zone and make a decision to remove the ERM and the need to remove the ILM

Sponsors

Makarenko Irina Romanovna
CollaboratorUNKNOWN
Zgoba Mariana Igorevna
CollaboratorUNKNOWN
The S.N. Fyodorov Eye Microsurgery State Institution
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 82 Years
Healthy volunteers
No

Inclusion criteria

* BCVA \< 0,6;

Exclusion criteria

. * secondary ERM, glaucoma, diabetic retinopathy, high myopia, BCVA\>0,6

Design outcomes

Primary

MeasureTime frameDescription
ILM integrityintraoperativeVisual intraoperative assessment of the ILM integrity
Length and localization of the ILM dialysisintraoperativeLength (in degrees) and localization of the ILM dyalisis
ILM displacementintraoperativeILM displacement direction during the formation of detachment and divulsion.
Occurence of ILM dyalisisintraoperativeDetermination of the ratio of patients with ILM dialysis to the total number of patients with ERF

Countries

Russia

Contacts

Primary ContactPavel V Lyskin, PhD
plyskin@yahoo.com+74994888926
Backup ContactIrina R Makarenko, MD
makarenkoirina505@gmail.com+79032101254

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026